☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
waldenstrom macroglobulinemia
BeiGene's Brukinsa (zanubrutinib) Receives Health Canada's Approval for Waldenström's Macroglobulinemia
March 3, 2021
BeiGene Report Results of Brukinsa (zanubrutinib) in P-III ASPEN Study for Waldenström's Macroglobulinemia
December 17, 2019
ONO Reports Submission of MAA to MHLW for Tirabrutinib Hydrochloride to Treat Waldenstrom Macroglobulinemia and Lymphoplasmacytic...
November 29, 2019
Janssen's Imbruvica (ibrutinib) Receives CHMP Positive Recommendation for its Expanded Use in Chronic Lymphocytic Leukaemia and Wa...
July 1, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.